Ignite Creation Date:
2025-12-18 @ 4:04 AM
Ignite Modification Date:
2025-12-23 @ 6:06 PM
Study NCT ID:
NCT00752336
Status:
None
Last Update Posted:
2008-09-15 00:00:00
First Post:
2008-09-12 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation
Sponsor:
None
Organization:
Study Overview
Official Title:
Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation
Status:
None
Status Verified Date:
2008-09
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Ergo-HTx
Brief Summary:
A prospective, interventional rehabilitation program was initiated to improve exercise tolerance and psychosocial functioning in patients after heart transplantation (HTx) and to evaluate long-term effects on health-related quality of life (HRQoL).Study subjects were randomized to either intervention or to control group and were followed with regular cardiopulmonary exercise testings and HRQoL measurements (SF-36) for 36±3 months after HTx. Patient characteristics did not differ concerning age, gender, and diagnosis at study entry. IG patients received regular psychosocial support and performed a home-based supervised ergometer training program. CG patients were recommended to perform regular exercising.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: